Abstracts
Showing 852 abstracts.
Citation
Linh Y. Ngo, F.N.P., Ram Yogev, M.D., Wayne M. Dankner, M.D., Walter T. Hughes, M.D., Jing Xu, M.S., Jashvant D. Unadkat, Ph.D. Pharmacokinetics of azithromycin (AZ) when administered alone and with atovaquone (AT). Presented at: 5th Conference on Retroviruses & Opportunistic Infections.Conference
5th Conference on Retroviruses & Opportunistic Infections
Citation
Anh P. Ta, Mary E. Paul, Nathan J. Hanan, Yanling Huo, Suad Kapetanovic, George Siberry, Elizabeth Smith, Pim Brouwers, Edmund V. Capparelli, Brookie M. Best. Pharmacokinetics of citalopram and escitalopram in HIV-infected and uninfected adolescents. Presented at: American Society of Health-System Pharmacists Midyear Clinical Meeting; 2017 Dec 04.Conference
American Society of Health-System Pharmacists Midyear Clinical Meeting
Study
P1080
Citation
Pharmacokinetics of Darunavir (DRV) 800 mg with Ritonavir 100 mg Once Daily in HIV-Infected Adolescents and Young Adults. Presented at: 20th Conference on Retroviruses and Opportunistic Infections.Conference
20th Conference on Retroviruses and Opportunistic Infections
Study
P1058A
Citation
J Momper, B Best, J Wang, A Stek, DE Shapiro, K George, E Barr, K Rungruengthanakit, E Smith, N Chakhtoura, EV Capparelli, M Mirochnick. Pharmacokinetics of darunavir boosted with cobicistat during pregnancy and postpartum. Presented at: IAS 2018.Conference
IAS 2018
Study
P1026S
Citation
J Momper, Brookie Best, J Wang, Alice Stek, David Shapiro, Kathy George, Emily Barr, Kittipong Rungruengthanakit, E Smith, N Chakhtoura, E Capparelli, M Mirochnick, IMPAACT P1026s Protocol Team. PHARMACOKINETICS OF DARUNAVIR BOOSTED WITH COBICISTAT DURING PREGNANCY AND POSTPARTUM. Presented at: CROI 2018.Conference
CROI 2018
Study
P1026S
Citation
Pharmacokinetics of Darunavir Once or Twice Daily During Pregnancy and Postpartum.Study
P1026S
Citation
Pharmacokinetics of Increased Dose Atazanavir with and without Tenofovir During Pregnancy. Presented at: 12th International Workshop on Clinical Pharmacology of HIV Therapy.Conference
12th International Workshop on Clinical Pharmacology of HIV Therapy
Study
P1026S
Citation
Alice Stek, Brookie Best, Edmund Caparrelli, JiaJia Wang, David Shapiro, Tim Cressey, Elizabeth Smith, Regis Kreitchman, Nahida Chakhtoura, Mark Mirochnick for the IMPAACT P1026s team. Pharmacokinetics of increased dose darunavir during late pregnancy and postpartum. Presented at: CROI 2016; 2016 Feb 23.Conference
CROI 2016
Study
P1026S
Citation
John H. Rodman, Pharm.D., Ram Yogev, M.D., Elaine J. Abrams, M.D., Stephen Ira Pelton, M.D., Pearl Samson, M.S., Terence Fenton, Ed.D., Ellen Gould Chadwick, M.D. Pharmacokinetics of Indinavir (IDV) at Two Dose Levels of Ritonavir (RTV) for HIV-infected Children Failing Antiretroviral Therapy.Study
P1013
Citation
Jennifer J. Kiser, Pharm.D., Sharon Appelbaum Nachman, M.D., Charles Debeaux Mitchell, M.D., George D. McSherry, M.D., Shabir A. Madhi, M.D., Avy Violari, M.D., Mark F. Cotton, MMED, Ph.D., MB ChB, Soyeon Kim, Ph.D., Heiner Seifart, Courtney V. Fletcher, Pharm.D. Pharmacokinetics of isoniazid in preventing tuberculosis disease and latent infection in African HIV-exposed uninfected and HIV-infected infants. Presented at: 47th Intersci Conf on Antimicrobial Agents & Chemotherapy.Conference
47th Intersci Conf on Antimicrobial Agents & Chemotherapy
Study
P1041